• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经根治性手术联合辅助放化疗成功治疗的晚期膀胱透明细胞腺癌。

Advanced clear-cell adenocarcinoma of the bladder successfully treated by radical surgery with adjuvant chemoradiotherapy.

作者信息

Kurosaka Shinji, Irie Akira, Mizoguchi Hideyuki, Okuno Norihiko, Iwabuchi Keiichi, Baba Shiro

机构信息

Department of Urology, Kitasato Institute Hospital, 5-9-1 Shirokane, Tokyo 108-8642, Japan.

出版信息

Int J Clin Oncol. 2005 Oct;10(5):362-5. doi: 10.1007/s10147-005-0497-6.

DOI:10.1007/s10147-005-0497-6
PMID:16247666
Abstract

A 52-year-old woman was referred to our institute for the evaluation of a tumor in her pelvic cavity. The tumor seemed to have arisen from the bladder or urethra, and bilateral iliac lymphadenopathy was seen. Her urethral mucosa looked intact according to the results of cystourethroscopy. Histopathological examination of the biopsy specimens showed clear-cell adenocarcinoma. She underwent radical cystourethrectomy with complete pelvic lymph node dissection and the construction of a bilateral ureterocutaneostomy. Macroscopically, the tumor had arisen from the trigone of the bladder, and histopathological examination of the tumor revealed adenocarcinoma exhibiting solid clear cells with glandular and papillary patterns. The tumor had infiltrated perivesical structure (pT3a), and metastases in multiple pelvic lymph nodes were recognized (pN3). Postoperatively, three courses of systemic combination chemotherapy with 5-fluouracil (FU) and cisplatin, along with a total of 45 Gy of irradiation during the second course of chemotherapy, were conducted. No evidence of the disease has been seen 28 months after the surgery.

摘要

一名52岁女性因盆腔肿物被转诊至我院。该肿物似乎起源于膀胱或尿道,且可见双侧髂淋巴结肿大。膀胱尿道镜检查结果显示其尿道黏膜完整。活检标本的组织病理学检查显示为透明细胞腺癌。她接受了根治性膀胱尿道切除术、盆腔淋巴结清扫术及双侧输尿管皮肤造口术。大体检查显示,肿瘤起源于膀胱三角区,肿瘤的组织病理学检查显示腺癌呈实性透明细胞,伴有腺管状和乳头状结构。肿瘤侵犯膀胱周围结构(pT3a),并在多个盆腔淋巴结发现转移(pN3)。术后,进行了三个疗程的5-氟尿嘧啶(FU)和顺铂全身联合化疗,在第二个化疗疗程期间共进行了45 Gy的放疗。术后28个月未见疾病复发迹象。

相似文献

1
Advanced clear-cell adenocarcinoma of the bladder successfully treated by radical surgery with adjuvant chemoradiotherapy.经根治性手术联合辅助放化疗成功治疗的晚期膀胱透明细胞腺癌。
Int J Clin Oncol. 2005 Oct;10(5):362-5. doi: 10.1007/s10147-005-0497-6.
2
Mesonephric adenocarcinoma of the urinary bladder: a case report.膀胱中肾腺癌:一例报告
Hinyokika Kiyo. 2000 Jan;46(1):27-31.
3
Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.根治性膀胱切除术和扩大盆腔淋巴结清扫术:仅接受手术治疗的髂总血管分叉以上淋巴结转移患者的生存率。
J Urol. 2007 Oct;178(4 Pt 1):1218-23; discussion 1223-4. doi: 10.1016/j.juro.2007.05.160. Epub 2007 Aug 14.
4
Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall.根治性膀胱切除术:扩大盆腔淋巴结清扫范围可提高局限于膀胱壁的膀胱癌患者的生存率。
J Urol. 1998 Dec;160(6 Pt 1):2015-9; discussion 2020.
5
Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.根治性膀胱切除术联合盆腔淋巴结整块清扫术后盆腔淋巴结转移患者的危险因素:淋巴结密度概念
J Urol. 2003 Jul;170(1):35-41. doi: 10.1097/01.ju.0000072422.69286.0e.
6
Clear cell adenocarcinoma of the bladder in a male patient: clinicopathologic analysis of a case.男性患者膀胱透明细胞腺癌:一例临床病理分析
Urol Int. 2003;71(2):228-30. doi: 10.1159/000071856.
7
Laparoendoscopic single-site radical cystectomy and pelvic lymph node dissection: initial experience and 2-year follow-up.腹腔镜单部位根治性膀胱切除术和盆腔淋巴结清扫术:初步经验和 2 年随访。
Urology. 2010 Oct;76(4):857-61. doi: 10.1016/j.urology.2010.04.024. Epub 2010 Jun 19.
8
[A case of squamous cell carcinoma of the bladder that was successfully treated with multidisciplinary therapies].
Hinyokika Kiyo. 2001 Jan;47(1):43-6.
9
Perioperative Chemotherapy in Advanced Bladder Cancer - Part II: Adjuvant Treatment.
Onkologie. 2003 Oct;26(5):484-8. doi: 10.1159/000072983.
10
Complete response of a recurrent advanced urachal carcinoma treated by S-1/cisplatin combination chemotherapy.S-1/顺铂联合化疗治疗复发性晚期脐尿管癌的完全缓解
Int J Urol. 2006 Aug;13(8):1123-5. doi: 10.1111/j.1442-2042.2006.01487.x.

引用本文的文献

1
Malignant transformation of nephrogenic adenoma of the bladder: case report and literature review.膀胱肾源性腺瘤的恶性转化:病例报告及文献综述
Transl Androl Urol. 2024 Nov 30;13(11):2651-2657. doi: 10.21037/tau-24-440. Epub 2024 Nov 25.
2
Progress in the treatment of urethral adenocarcinoma.尿道腺癌的治疗进展
J Cancer Res Clin Oncol. 2023 Jun;149(6):2693-2698. doi: 10.1007/s00432-022-04481-5. Epub 2022 Nov 21.
3
Primary Clear Cell Carcinoma of the Urinary Bladder.膀胱原发性透明细胞癌

本文引用的文献

1
Clear cell adenocarcinoma of the bladder in a male patient: clinicopathologic analysis of a case.男性患者膀胱透明细胞腺癌:一例临床病理分析
Urol Int. 2003;71(2):228-30. doi: 10.1159/000071856.
2
Clear cell adenocarcinoma of the urinary bladder inducing acute renal failure.
Int J Urol. 2002 Aug;9(8):467-9. doi: 10.1046/j.1442-2042.2002.00496.x.
3
Cyclophosphamide and 5-fluorouracil act synergistically in ovarian clear cell adenocarcinoma cells.
Cancer Lett. 2001 Jan 10;162(1):39-48. doi: 10.1016/s0304-3835(00)00605-4.
4
Int Sch Res Notices. 2014 Jul 2;2014:593826. doi: 10.1155/2014/593826. eCollection 2014.
4
Clear-cell adenocarcinoma of vesical origin: a case study of metastatic disease treated with chemotherapy.膀胱源性透明细胞腺癌:1例化疗治疗转移性疾病的病例研究
Chemother Res Pract. 2010;2010:426973. doi: 10.1155/2010/426973. Epub 2010 Oct 17.
5
Primary clear cell adenocarcinoma of the bladder with recurrence: a case report and literature review.膀胱原发性透明细胞腺癌伴复发:病例报告及文献复习。
World J Surg Oncol. 2012 Feb 10;10:33. doi: 10.1186/1477-7819-10-33.
Malignant transformation in endometriosis of the urinary bladder: case report of clear cell adenocarcinoma.膀胱子宫内膜异位症的恶性转化:透明细胞腺癌病例报告
Eur J Gynaecol Oncol. 1996;17(1):13-6.
5
Clear cell adenocarcinoma of the urinary bladder: report of a case of probable müllerian origin.膀胱透明细胞腺癌:一例可能起源于苗勒管的病例报告。
Mod Pathol. 1993 Mar;6(2):225-8.
6
Immunohistochemical identification of prostatic acid phosphatase and prostate specific antigen in female periurethral glands.
Urology. 1984 Mar;23(3):303-4.
7
Mesonephric adenocarcinoma of the bladder.
J Urol. 1968 Oct;100(4):466-9. doi: 10.1016/s0022-5347(17)62554-0.
8
Mixed mesonephric adenocarcinoma and transitional cell carcinoma of the bladder.
Histopathology. 1990 Jun;16(6):601-4. doi: 10.1111/j.1365-2559.1990.tb01167.x.
9
Clear cell adenocarcinoma of the urethra: evidence for origin within paraurethral ducts.
J Urol. 1990 Jan;143(1):122-5. doi: 10.1016/s0022-5347(17)39887-7.